Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 55 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 9120868

    Recombinantly expressed Plasmodium CelTOS antigen and methods of use thereof

    The United States of America as represented by the Secretary of the Army · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  2. US 9114102

    Method of inhibiting ABCG2 and related treatments

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  3. US 9115371

    Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  4. US 9115187

    Identification of antibodies specific for lyssaviruses and methods of their use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  5. US 9114151

    Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria

    THE UNITED STATES OF AMERICA DEPT. OF VETERANS AFFAIRS · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  6. US 9115205

    Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression

    The United States of America as represented by the Secretary of the Army · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  7. US 9115094

    Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using

    The United States of America National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS) · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  8. US 9107938

    Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted

  9. US 9101601

    Methods of treating or preventing insulin resistance and associated diseases and conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  10. US 9102831

    Process for producing improved zein articles

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  11. US 9101600

    Compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  12. US 9101582

    Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  13. US 9097713

    Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  14. US 9096653

    Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  15. US 9095597

    N-acetyl mannosamine as a therapeutic agent

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  16. US 9090873

    Development of dengue virus vaccine components

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  17. US 9084761

    Use of interleukin-15 to treat cardiovascular diseases

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  18. US 9084820

    Magnetic microstructures for magnetic resonance imaging

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  19. US 9084783

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  20. US 9085604

    Antiproliferative factor and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  21. US 9084819

    Magnetic microstructures for magnetic resonance imaging

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  22. US 9079974

    GH-RH analogs with potent agonistic effects

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  23. US 9079936

    Derivatives of APF and methods of use

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  24. US 9074185

    Adoptive cell therapy with young T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.